Showing results (1-10 of 933) with videos related to
Sort By:
Pageof 94
Hepatology International|December 6, 2019
New drugs for NAFLD: lessons from basic models to the clinicKatharina C Reimer, Alexander Wree, Christoph Roderburg, et al.Deutsche Medizinische Wochenschrift (1946)|November 17, 2020
[The Gastrointestinal Tract in Intensive Care Medicine - Overview 2020]Alexander Wree, Christoph Roderburg, Frank TackeHepatic Oncology|July 11, 2020
Systemic treatment of hepatocellular carcinoma: from sorafenib to combination therapiesChristoph Roderburg, Burcin Özdirik, Alexander Wree, et al.Hepatic Oncology|April 11, 2020
The role of the innate immune system in the development and treatment of hepatocellular carcinomaChristoph Roderburg, Alexander Wree, Münevver Demir, et al.International Journal of Molecular Sciences|July 19, 2020
In Vivo Models for Cholangiocarcinoma-What Can We Learn for Human Disease?Raphael Mohr, Burcin Özdirik, Jana Knorr, et al.Visceral Medicine|July 15, 2016
Antiviral Therapy in Patients with Viral Hepatitis and Hepatocellular Carcinoma: Indications and PrognosisChristoph Roderburg, Frank Tacke, Christian TrautweinInternational Journal of Molecular Sciences|June 26, 2019
Somatostatin Analogues in the Treatment of Neuroendocrine Tumors: Past, Present and FutureAnna Kathrin Stueven, Antonin Kayser, Christoph Wetz, et al.Alimentary Pharmacology & Therapeutics|March 8, 2023
Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma: Results from a German real-world cohortFabian Jost-Brinkmann, Münevver Demir, Alexander Wree, et al.Zeitschrift Fur Gastroenterologie|July 10, 2019
[Microbiome & NASH - partners in crime driving progression of fatty liver disease]Alexander Wree, Lukas Jonathan Geisler, Frank TackeJournal of Hepatocellular Carcinoma|February 15, 2023
Preoperative Immunotherapy in Hepatocellular Carcinoma: Current State of the ArtAlena Laschtowitz, Christoph Roderburg, Frank Tacke, et al.Pageof 94